1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Multiple Sclerosis (Relapsing Remitting): new trials by email Literature Review of Multiple Sclerosis (Relapsing Remitting) trials Research Report on Multiple Sclerosis (Relapsing Remitting)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Fingolimod in MS Patients in China fingolimod, Placebo (6mos) + open label fingolimod (6 mos) - Multiple Sclerosis (Relapsing Remitting) | Phase 3 | Withdrawn | Novartis Pharmaceuticals | 2014-06-01 | 2017-04-21 |
Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Nervous System Diseases (1)